Blog - Page 1138 of 5757

TuesdayJan 25, 2022 12:06 pm

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Reports Findings of Commissioned Study Showing a Majority of Affected Americans Approve of Psychedelics as an Alternative Treatment for Select Mental Conditions

The Harris Poll conducted a survey on behalf of Delic Holdings, polling 2,037 adults ages 18 and older, 953 of whom suffer from anxiety/depression/PTSD The survey revealed that 65% of Americans living with anxiety/depression/PTSD believe that psychedelic medicine should be available to patients with treatment-resistant conditions 66%, 62%, and 56% are open to pursuing ketamine, psilocybin, and MDMA, respectively, to treat anxiety/depression/PTSD if these psychedelic drugs were each proven more effective than prescription medication with fewer side effects Though the U.S. government has not yet federally recognized a medical use for most psychedelic drugs, research by renowned universities and companies…

TuesdayJan 25, 2022 11:23 am

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Ranked No. 1 Globally in Multi-Cancer Screening and Detection Test Volume

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, today announced that Frost & Sullivan Company, a leading and well-known U.S. market analysis and research firm, has ranked AnPac Bio globally as number one in worldwide multiple cancer screening and detection volume in a recent research report. Based on data accumulated through the end of 2020, the report included next generation cancer screening and detection technologies, including circulating tumor cells (“CTCs”), circulating-DNA (“CT-DNA”), exosome, cancer differentiation analysis (“CDA”), mRNA, and other emerging technologies. Specifically, for next generation cancer screening and detection, the report ranked…

TuesdayJan 25, 2022 11:14 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Marks Significant Milestone in Pursuit of Berubicin Approval for Global GBM Treatment, Raises $11.5 Million from Private Placement

CNS Pharmaceuticals received approval from swissethics for its potentially pivotal study of Berubicin, a novel anthracycline for the treatment of Glioblastoma Multiforme (“GBM”) The approval is the first from a European Ethics Committee The company, which dosed the first patients in its Berubicin program in September, has selected multiple clinical sites across the U.S., Spain, France, Italy, and Switzerland CNS recently closed an $11.5 million private placement It intends to use the net proceeds to fund its clinical trials and preclinical programs, other R&D programs, and for general corporate purposes Clinical stage biotechnology company CNS Pharmaceuticals (NASDAQ: CNSP) is celebrating…

TuesdayJan 25, 2022 10:47 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF): a 2021 Overall Review

FuelPositive has hit multiple milestones throughout 2021, starting with its rebranding in January that ushered it into the world of green hydrogen and ammonia In March, the company acquired the intellectual property for its green ammonia production technology In May, FuelPositive began building its prototype production systems in collaboration with the National Compressed Air in Toronto and is on track to launch multiple real-world demonstration pilot projects throughout 2022 The modular, scalable green ammonia production systems offer numerous benefits, including zero carbon emissions and cheaper production costs than traditional grey ammonia production On January 19, 2021, shareholders, during the annual…

TuesdayJan 25, 2022 10:26 am

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Announces Staggering 800% Increase in 2021 Processing Volume

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has announced preliminary unaudited results for 2021 with a processing record of $1.95 billion in transaction volume, compared to $202 million during the previous year. This represents a staggering increase of over 800% in processing volume, leading to revenues of at least $26.0 million, an over 200% increase when compared to 2020 revenues of $8.5 million. “2020 unquestionably proved our ability to develop and deploy cutting-edge technology. In 2021 we focused on executing on our strategy to build sustainable scale for our products, while adding new leadership team members that…

MondayJan 24, 2022 1:53 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Appoints Renowned Genetics, Cultivation Expert as Advisor

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has named Derek Pedro, an industry-leading cannabis genetics and cultivation expert, as an advisor. Pedro is recognized as a pioneer in the cannabis industry and has consulted on cannabis genetic and cultivation projects around the world, including Canada, the United States, Latin America, Europe and China. In his role at FLGC, he will focus on developing the company’s current register of high-THC and high-CBD strains. The company hopes to offer cannabis flower offerings that are uniquely Colombian to both domestic and international markets. Flora…

MondayJan 24, 2022 1:31 pm

QualityStocksNewsBreaks — Growth Capital Acquisition Corp. (NASDAQ: GCAC), Cepton Technologies Inc. Merger to Be Discussed at Upcoming Investor Day

Growth Capital Acquisition Corp. (NASDAQ: GCAC), a publicly traded special purpose acquisition company, and its upcoming merger with Cepton Technologies Inc., a Silicon Valley innovator and leader in high performance MMT(R) lidar solutions, will be the focus of a virtual investor day event. The event is scheduled for Thursday, Jan. 27, 2022, at 12 p.m. ET. The event will be hosted by Cepton management and will include a discussion about recent industry trends as well as an update regarding the pending transaction. The webinar will be broadcast live with a replay available on the company website following the event. The…

MondayJan 24, 2022 1:20 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution

Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices The company recently announced the rollout of its Miboko application by targeting insurers and employers In 2019, over $760 billion was spent on diabetes-related health care, equating to $9,000 per diabetic patient compared to $1,600 for a non-diabetic individual The Miboko application provides users with an efficient and accurate means of tracking their day-to-day glycaemic levels, a key determinant of overall metabolic health Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs,…

MondayJan 24, 2022 1:12 pm

Friendable Inc. (FDBL) Discloses Driving Factors Behind Acquisition of Artist Republik and Benefits to Fan Pass Live Artist Platform

Since Summer 2021, Friendable has been searching for the right music distribution platform to pair with its successful flagship offering, Fan Pass Live The acquisition of Artist Republik brings an additional 100,000 artists to the platform and an extensive tech deck that will benefit all parties The Artist Republik acquisition provides independent artists with access to a distribution offering, which they would not have unless they paid additional for management and were assigned to a record label Mobile technology and marketing company Friendable (OTC: FDBL) is releasing more details about the recent acquisition of Artist Republik, a reputable music distribution…

MondayJan 24, 2022 1:07 pm

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Strengthens its Commitment to the Red Lake Mining District Following Approval of its Exploration Permit for RLX

StraightUp received its early exploration permit that allows it to begin exploration activities on the eastern block of its RLX North property The company will be taking a systematic approach to developing and testing gold targets as it plans to execute its 2022 work programs which will include drilling prospective targets in the summer This approval strengthens StraightUp’s commitment to the Red Lake Mining District, having expressed the intention to acquire 100% undivided interest in the RLX property back in September 2021 StraightUp also announced the appointment of Jacqueline Collins as the company’s new Corporate Secretary StraightUp Resources (CSE: ST)…

Site Search

Company Search